Table 2. Study outcomes (N = 433) of included RCTs (Detailed table per CVAD type in S4 Table).
Reported Study Outcomes | Totals | |
---|---|---|
Catheter complications, N (%) | 99 (22.9%) | |
Thrombosis | 29 (6.7%) | |
Occlusion | 23 (5.3%) | |
Mechanical failure a | 15 (3.4%) | |
Early removal | 14 (3.3%) | |
Dwell time | 12 (2.8%) | |
Complication rate (not specified) | 5 (1.2%) | |
Local edema/ inflammation | 1 (0.2%) | |
Patient outcomes, N (%) | 29 (6.6%) | |
Pain scores | 14 (3.2%) | |
Patient satisfaction/ Quality of life | 6 (1.4%) | |
Vital signs | 3 (0.7%) | |
Mortality rate | 3 (0.7%) | |
Psychological distress | 1 (0.2%) | |
Patient comprehension | 1 (0.2%) | |
Self-management ability | 1 (0.2%) | |
Catheter insertion outcomes, N (%) | 101 (23.3%) | |
Successful placement measures | 47 (10.9%) | |
Insertion-related complications | 39 (9.0%) | |
Insertion success: performance scores | 13 (3.0%) | |
Use of ultrasound | 1 (0.2%) | |
Requirement for repositioning | 1 (0.2%) | |
Infective outcomes, N (%) | 161 (37.2%) | |
Catheter-related blood stream infection | 47 (10.9%) | |
Catheter-related infection | 29 (6.7%) | |
CVAD tip colonization | 29 (6.7%) | |
Contamination/ colonization of non-catheter materials including skin and hub | 20 (4.6%) | |
Systemic infection/sepsis/ fever | 18 (4.2%) | |
Local infection/ exit-site infection/phlebitis | 17 (3.9%) | |
Microbial biofilm | 1 (0.2%) | |
Patency-related outcomes, N (%) | 10 (2.3) | |
Patency | 5 (1.2%) | |
Thrombolytic/ fibrinolysis injection | 4 (0.9%) | |
Anticoagulant treatment | 1 (0.2%) | |
Intervention-related outcomes, N (%) | 21 (4.8%) | |
Side effects/ tolerability | 16 (3.7%) | |
Bleeding | 4 (0.9%) | |
Skin necrosis | 1 (0.2%) | |
Health service-related outcomes, N (%) | 12 (2.8%) | |
Health economics/cost | 12 (2.8%) | |
TOTAL | 433 (100%) |
a Mechanical failures include migration, catheter defects, malfunction, infiltration, skin fixation failure, dislocation, fracture and other.